22 Nw, LP Anebulo Pharmaceuticals, Inc. Transaction History
22 Nw, LP
- $86 Million
- Q2 2024
A detailed history of 22 Nw, LP transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, 22 Nw, LP holds 5,366,290 shares of ANEB stock, worth $10.4 Million. This represents 17.03% of its overall portfolio holdings.
Number of Shares
5,366,290
Previous 5,366,290
-0.0%
Holding current value
$10.4 Million
Previous $15.4 Million
4.88%
% of portfolio
17.03%
Previous 15.16%
Shares
4 transactions
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.31MCall Options Held
0Put Options Held
0-
Lvw Advisors, LLC642KShares$1.24 Million0.26% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$986,3700.09% of portfolio
-
Morgan Stanley New York, NY399KShares$770,4920.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$304,6730.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA154KShares$296,9740.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $49.5M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...